MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Silencing dopamine neurons during sleep slows disease progression in parkinsonian mice

    C. Meng, G. Cui (Research Triangle Park, USA)

    Objective: To develop a treatment to stop or slow the progression of Parkinson's disease. Background: Parkinson’s disease (PD) is believed to be caused by the…
  • 2022 International Congress

    Mortality in Parkinson’s patients following Covid19 infection in the second wave of the pandemic

    G. Desai, T. Nanayakkara, G. Pun, A. Chatterjee, N. Butt (Reading, United Kingdom)

    Objective: To analyze causes of mortality and death certification in Parkinson’s disease patients who had SARS- CoV2 in Reading, West Berkshire, United Kingdom (UK) Background:…
  • 2022 International Congress

    Childhood Trauma and Parkinson’s Disease: Associations of Adverse Childhood Experiences, Disease Severity and Quality of Life

    I. Subramanian, B. Mcdaniels, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: Objective: The goal of this study was to survey individuals with PD to evaluate whether intensity of childhood trauma is associated with individual symptoms,…
  • 2022 International Congress

    Neurodegeneration associated with pantothenate kinase in a Mexican Patient: Solving the Diagnostic Challenge of the Eye of Tiger

    M. Arbeu Reyes, B. Madariaga Cortés, C. Aguilar Vázquez (Mexico City, Mexico)

    Objective: To describe the case of a patient with PKAN in Mexico, where we have a few information about inherited movement disorders, which makes the…
  • 2022 International Congress

    Patient-Specific Outcomes of Transcutaneous Afferent Patterned Stimulation with Varying Frequencies for Essential Tremor and Parkinson’s Disease

    A. Kent, H. Kim, D. Khosla, K. Rosenbluth (Foster City, USA)

    Objective: Two studies were conducted to compare the safety, effectiveness, and comfort of fixed- and variable-frequency transcutaneous afferent patterned stimulation (TAPS) for action tremor relief…
  • 2022 International Congress

    Ballet for Parkinson’s disease, a new concept: Remote delivery via the English National Ballet’s Dance for Parkinson’s programme

    A. Podlewska, R. Davis, L. Batzu, P. Tall, F. Derbyshire-Fox, A. Hartley, N. Sevdalis, A. Woods, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To explore the characteristics and subjective outcomes for People with Parkinson’s (PwP) attending online Dance for Parkinson’s sessions professionally delivered by the English National…
  • 2022 International Congress

    Exploring the morning akinesia in Parkinson’s disease with the wearable sensor STAT-ON

    N. Caballol, C. Pérez-López, A. Pérez-Soriano, A. Planas-Ballvé, A. ávila, P. Quispe, A. Bayés (Sant Joan Despí, Spain)

    Objective: To detect the morning akinesia (MA) through the analysis of the gait fluidity (GF) measured by the sensor STAT-ON. Background: The STAT-ON sensor's detection…
  • 2022 International Congress

    Clinical and electrophysiological validation of a volume of tissue activation model for directional deep brain stimulation leads – the ReCaps study

    P. Capetian, F. Lange, T. Binder, G. Brandt, R. Peach, J. Volkmann, D. Zeller (Wuerzburg, Germany)

    Objective: Assessing the predictive value of a volume of tissue activation (VTA) model for directional deep brain stimulation (DBS) leads on the response threshold of…
  • 2022 International Congress

    Heterozygous mutations in the Parkin gene – two different presentations of Parkinson’s disease

    F. Barros, J. Alves, D. Reis-Carneiro, F. Moreira, A. Morgadinho (Coimbra, Portugal)

    Objective: The main objective of this work is to present two Parkinson's disease (PD) patients with heterozygous mutations in the Parkin gene (PARK – parkin)…
  • 2022 International Congress

    Dopa-responsive Combined Dystonia Due to ATP1A3 Gene Variant

    M. Soares, J. Parmera, M. Bezerra (São Paulo, Brazil)

    Objective: To describe a remarkable case of a patient with an atypical ATP1A3 phenotype with levodopa responsiveness, expanding our understanding of this gene mutation. Background: The ATP1A3-spectrum disorders…
  • « Previous Page
  • 1
  • …
  • 633
  • 634
  • 635
  • 636
  • 637
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley